Caseware UK (AP4) 2023.0.135 2023.0.135 2024-06-302024-06-302023-07-01false1017falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 10828594 2023-07-01 2024-06-30 10828594 2022-07-01 2023-06-30 10828594 2024-06-30 10828594 2023-06-30 10828594 c:Director1 2023-07-01 2024-06-30 10828594 d:FurnitureFittings 2023-07-01 2024-06-30 10828594 d:FurnitureFittings 2024-06-30 10828594 d:FurnitureFittings 2023-06-30 10828594 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-07-01 2024-06-30 10828594 d:Goodwill 2023-07-01 2024-06-30 10828594 d:Goodwill 2024-06-30 10828594 d:Goodwill 2023-06-30 10828594 d:CurrentFinancialInstruments 2024-06-30 10828594 d:CurrentFinancialInstruments 2023-06-30 10828594 d:Non-currentFinancialInstruments 2024-06-30 10828594 d:Non-currentFinancialInstruments 2023-06-30 10828594 d:CurrentFinancialInstruments d:WithinOneYear 2024-06-30 10828594 d:CurrentFinancialInstruments d:WithinOneYear 2023-06-30 10828594 d:Non-currentFinancialInstruments d:AfterOneYear 2024-06-30 10828594 d:Non-currentFinancialInstruments d:AfterOneYear 2023-06-30 10828594 d:ShareCapital 2024-06-30 10828594 d:ShareCapital 2023-06-30 10828594 d:RetainedEarningsAccumulatedLosses 2024-06-30 10828594 d:RetainedEarningsAccumulatedLosses 2023-06-30 10828594 c:FRS102 2023-07-01 2024-06-30 10828594 c:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 10828594 c:FullAccounts 2023-07-01 2024-06-30 10828594 c:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 10828594 2 2023-07-01 2024-06-30 10828594 d:Goodwill d:OwnedIntangibleAssets 2023-07-01 2024-06-30 10828594 e:PoundSterling 2023-07-01 2024-06-30 iso4217:GBP xbrli:pure

Registered number: 10828594










ABAX HEALTH LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 JUNE 2024

 
ABAX HEALTH LIMITED
REGISTERED NUMBER: 10828594

STATEMENT OF FINANCIAL POSITION
AS AT 30 JUNE 2024

2024
2023
Note
£
£

Fixed assets
  

Intangible assets
 4 
360,000
400,000

Tangible assets
 5 
41,185
36,089

  
401,185
436,089

Current assets
  

Stocks
  
43,202
42,000

Debtors: amounts falling due after more than one year
 6 
-
214,049

Debtors: amounts falling due within one year
 6 
186,784
2,956

Cash at bank and in hand
  
136,349
160,942

  
366,335
419,947

Creditors: amounts falling due within one year
 7 
(284,658)
(234,678)

Net current assets
  
 
 
81,677
 
 
185,269

Total assets less current liabilities
  
482,862
621,358

Creditors: amounts falling due after more than one year
 8 
(246,226)
(481,336)

Provisions for liabilities
  

Deferred tax
  
(10,296)
-

  
 
 
(10,296)
 
 
-

Net assets
  
226,340
140,022


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
226,240
139,922

  
226,340
140,022


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

Page 1

 
ABAX HEALTH LIMITED
REGISTERED NUMBER: 10828594
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 30 JUNE 2024

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 2 March 2025.




Mr S N Ghasemi
Director

The notes on pages 3 to 9 form part of these financial statements.

Page 2

 
ABAX HEALTH LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

1.


General information

Abax Health Limited is a private company, limited by share capital, incorporated in England and Wales under registration number 10828594. The address of the company's registered office is Newport Pharmacy, The Brown House, High Street, Newport, Saffron Walden, CB11 3QY.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

Page 3

 
ABAX HEALTH LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

2.Accounting policies (continued)

 
2.3

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.6

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.7

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the Company in independently administered funds.

Page 4

 
ABAX HEALTH LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

2.Accounting policies (continued)

 
2.8

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.


 
2.9

Intangible assets

Goodwill

Goodwill represents the difference between amounts paid on the cost of a business combination and the acquirer’s interest in the fair value of its identifiable assets and liabilities of the acquiree at the date of acquisition. Subsequent to initial recognition, goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is amortised on a straight-line basis to the Statement of comprehensive income over its useful economic life.

Other intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 The estimated useful lives range as follows:

Goodwill
-
10
years

Page 5

 
ABAX HEALTH LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

2.Accounting policies (continued)

 
2.10

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Fixtures and fittings
-
25%
Reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.11

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.12

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.13

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.14

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 6

 
ABAX HEALTH LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

2.Accounting policies (continued)

 
2.15

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.


3.


Employees

The average monthly number of employees, including directors, during the year was 10 (2023 - 17).


4.


Intangible assets




Goodwill

£



Cost


At 1 July 2023
400,000



At 30 June 2024

400,000



Amortisation


Charge for the year on owned assets
40,000



At 30 June 2024

40,000



Net book value



At 30 June 2024
360,000



At 30 June 2023
400,000



Page 7

 
ABAX HEALTH LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

5.


Tangible fixed assets





Fixtures and fittings

£



Cost or valuation


At 1 July 2023
67,121


Additions
18,824



At 30 June 2024

85,945



Depreciation


At 1 July 2023
31,032


Charge for the year on owned assets
13,728



At 30 June 2024

44,760



Net book value



At 30 June 2024
41,185



At 30 June 2023
36,089


6.


Debtors

2024
2023
£
£

Due after more than one year

Amounts owed by associated company
-
214,049

-
214,049


2024
2023
£
£

Due within one year

Trade debtors
151,546
326

VAT repayable
24,786
2,630

Prepayments and accrued income
10,452
-

186,784
2,956


Page 8

 
ABAX HEALTH LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Bank loan
18,620
13,068

Trade creditors
216,331
194,995

Other creditors
14,268
18,960

Corporation tax
33,261
-

Other taxation and social security
1,478
7,655

Accruals and deferred income
700
-

284,658
234,678


Bank loan is secured by fixed and floating charge over the assets of the company.


8.


Creditors: Amounts falling due after more than one year

2024
2023
£
£

Bank loan
173,266
189,086

Other loans
-
169,537

Director's loan account
72,960
122,713

246,226
481,336


Bank loan is secured by fixed and floating charge over the assets of the company.


9.


Controlling party

The company was under the control of the sole director Mr S N Ghasemi, by virtue of the fact that he owns 100% of the issued share capital.

 
Page 9